ArticleHemaSphere2023

Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data.

Jérôme Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.